[A clinical evaluation of MAb BW 835/6 in breast and ovarian cancer].
Studies with the 99mTc-labeled murine monoclonal antibody BW 835/6 in patients suspected of breast (n = 7) or ovarian cancer (n = 8) showed insufficient depiction of primary tumors and metastases of breast cancer, but promising results in the detection of primary tumors in ovarian cancer without metastases. The small number of patients does not allow statistical analysis.
Trampert
L
L
Abteilung für Nuklearmedizin, Universitätskliniken Homburg/Saar, FRG.
Villena
C
C
Benz
P
P
Keweloh
H C
HC
Schmidt
W
W
Oberhausen
E
E
D000328:Adult; D000368:Aged; D001943:Breast Neoplasms / Q000000981:diagnostic imaging*; D005260:Female; D006801:Humans; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000000981:diagnostic imaging*; D016719:Radioimmunodetection; D013667:Technetium
D013667:Technetium
Klinische Prüfung mit MAk BW 835/6 bei Mamma- und Ovarialkarzinomen.